A/H5N1in Adult - Aventis

计划入组 452 人 · 首次发布于 2005 年 6 月 27 日

Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer

计划入组 51 人 · 首次发布于 2011 年 4 月 8 日

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

计划入组 38 人 · 首次发布于 2009 年 3 月 11 日

Civ1 inhibitors (sanofi-aventis)

RU-75411

urotensin II receptor antagonists (Aventis)

AVENTIS PHARMA

Egypt

SANOFI-AVENTIS FRANCE

France

SANOFI AVENTIS GROUP

Saudi Arabia

FDA Approves Sanofi's Multaq for Atrial Fibrillation Patients, Marking First New Treatment in Two Decades

FDA Approves First Rapid-Acting Insulin Biosimilar Merilog for Diabetes Management

Federal Circuit Rules Against Teva's Orange Book Patent Listings for ProAir HFA Inhaler